Hassan Sahuur Abdullahi Ahmed Sheikh, Wiil Uffe Kock, Ebrahimi Ali
SDU Health Informatics and Technology, The Maersk Mc-Kinney Moller Institute, University of Southern Denmark, 5230 Odense, Denmark.
Audiol Res. 2025 Jun 19;15(3):73. doi: 10.3390/audiolres15030073.
This systematic review aimed to evaluate the diagnostic accuracy of self-administered web- and app-based tools for audiometric testing compared to pure-tone audiometry (PTA), the clinical gold standard. Studies were eligible if they involved human participants, evaluated self-administered digital tools for audiometric testing, reported diagnostic accuracy metrics (e.g., sensitivity, specificity, and accuracy), were published between 2014 and 2024, and were written in English. Studies were excluded if they did not compare to PTA, were reviews, or did not assess self-administered tools. MEDLINE, Web of Science, Scopus, and EMBASE were systematically searched throughout November 2024. Study quality was assessed using the QUADAS-2 tool, evaluating four domains: patient selection, index test, reference standard, and flow and timing. Most studies showed some concern for a risk of bias. Twelve studies, including a total of 2453 participants and evaluating 15 applications, met the inclusion criteria. The studies reported wide variability in diagnostic accuracy. Sensitivity ranged from 18% to 100%, specificity from 35.5% to 99.1%, and accuracy from 14% to 97.4%. SHOEBOX and Screenout demonstrated high diagnostic accuracy, while other apps showed inconsistent results across studies and settings. Heterogeneity in definitions of hearing loss, test environments, device and headphone types and a lack of standardized reporting limited comparability. Most studies were conducted in non-soundproof environments, and some had unclear or a high risk of bias. Self-administered audiometric apps and web tools show promise for remote hearing screening but require further validation and methodological standardization. Clinicians should interpret the results cautiously given the current variability in performance.
本系统评价旨在评估与临床金标准纯音听力测试(PTA)相比,基于网络和应用程序的自我管理听力测试工具的诊断准确性。如果研究涉及人类参与者、评估自我管理的数字听力测试工具、报告诊断准确性指标(如敏感性、特异性和准确性)、发表于2014年至2024年之间且为英文撰写,则该研究符合纳入标准。如果研究未与PTA进行比较、为综述或未评估自我管理工具,则将其排除。于2024年11月对MEDLINE、科学网、Scopus和EMBASE进行了系统检索。使用QUADAS - 2工具评估研究质量,评估四个领域:患者选择、索引测试、参考标准以及流程和时间安排。大多数研究显示存在一些偏倚风险。十二项研究,共纳入2453名参与者并评估了15种应用程序,符合纳入标准。这些研究报告的诊断准确性差异很大。敏感性范围为18%至100%,特异性范围为35.5%至99.1%,准确性范围为14%至97.4%。SHOEBOX和Screenout表现出较高的诊断准确性,而其他应用程序在不同研究和环境中的结果不一致。听力损失定义、测试环境、设备和耳机类型的异质性以及缺乏标准化报告限制了可比性。大多数研究在非隔音环境中进行,一些研究存在偏倚风险不明确或较高的情况。自我管理的听力测试应用程序和网络工具在远程听力筛查方面显示出前景,但需要进一步验证和方法标准化。鉴于目前性能的变异性,临床医生应谨慎解读结果。